Journal of Pain and Symptom Management
Volume 40, Issue 5 , Pages e1-e2 , November 2010

Potential Opioid-Sparing Effect of Regular Benzodiazepines in Dyspnea: Longer Duration of Studies Needed

References 

  1. Navigante AH, Castro MA, Cerchietti LC. Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated. J Pain Symptom Manage. 2010;39:820–830
  2. Currow DC, Wheeler J, Glare P, Kaasa S, Abernethy AP. A framework for generalizability in palliative care. J Pain Symptom Manage. 2009;37:373–386
  3. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939–944
  4. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327:523–528

PII: S0885-3924(10)00538-5

doi: 10.1016/j.jpainsymman.2010.07.002

Journal of Pain and Symptom Management
Volume 40, Issue 5 , Pages e1-e2 , November 2010

Article Tools